Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up Spotlight

Set Alert for Start-Up Spotlight

Start-Up Spotlight: Creavo Medical, Diagnosing Myocardial Ischaemia With MCG

UK medtech company Creavo Medical Technologies is trying to bring its magnetocardiography (MCG) technology to emergency departments worldwide to help physicians accurately rule out heart disease. Distinguishing between ischemic heart disease and non-cardiac chest pain remains a challenge in emergency departments. Currently, all patients presenting with chest pain are assessed with electrocardiography and blood tests to rule out heart disease, but almost three-quarters of patients with chest pain do not have a cardiac-related condition. 

Start-up Spotlight Cardiovascular Commercial

QUOTED. Dec. 4, 2018. John Scandurra.

Aria CV hopes to address pulmonary hypertension, a potential devastating condition that currently has few treatments, with a unique balloon device that requires no power supply, battery, pump, or synchronization. See what Aria CEO John Scandurra said about it here.

Quoted Companies

Start-Up Spotlight: Aria CV Addresses Right-Heart Failure With Purely Mechanical Solution

St. Paul-based Aria CV is developing a "passive" pulmonary artery balloon system to treat pulmonary hypertension and impede the development of heart failure. Following a successful first-in-human study, the company is currently developing a feasibility study it expects will lead to a US pivotal trial in several years.

Start-up Spotlight Companies

Start-Up Spotlight: GNS Healthcare Deploys Causal Algorithms To Drive Health Outcomes, Save Costs

GNS Healthcare wants to be on the forefront of the digital revolution in health care by offering its artificial intelligence powers to pharmaceutical and health-insurer customers to help them find the drivers of health outcomes and save costs along the way. It has also teamed up with research and patient foundations to expedite the R&D process, predict best treatment options for patients and create efficiencies for clinical trials.

Artificial Intelligence Commercial

Start-Up Spotlight: Bay Labs' AI Technology Paves Way To Retailer Echo Testing

In an effort to make cardiac imaging more accessible and to lead to more appropriate diagnosis of cardiac disease, Bay Labs Inc. is developing software algorithms designed to allow echocardiography to be performed by non-specialists in echo, including medical providers such as nurses and physician assistants. The backbone of the technology is artificial intelligence (AI), specifically deep-learning algorithms.

Cardiovascular Commercial

Device Week, Sept. 13, 2018 – A Big Week For LivaNova; Creavo Seeks Cardiac Test Breakthrough

In this edition of the Device Week podcast, Medtech Insight’s Reed Miller talks about the latest good news for LivaNova and Catherine Longworth provides an update on Creavo Medical, a UK-based company using an old technology for a new kind of cardiac test that could save hospitals money.

Device Week Cost Effectiveness

Start-Up Spotlight: Vivior's Wearable Eye Monitor Seeks To Sharpen Vision Correction

Swiss-based Vivior AG has developed a wearable Visual Behavior Monitor (VBM) designed to help surgical ophthalmologists determine the best treatment options for patients. The company's initial target is the $2.15bn global refractive and cataract surgery market.

Ophthalmic Innovation
See All
UsernamePublicRestriction

Register